34^th European Diabetes Congress

Arturo Solis Herrera has done his PhD in Pharmacology. He has done his MD with specialty in Ophthalmology. He is the Director and Founder of Human Photosynthesis® Research Center. He has published more than 30 papers and five books on melanin Arturo Solis Herrera has done his PhD in Pharmacology. He has done his MD with specialty in Ophthalmology. He is the Director and Founder of Human Photosynthesis® Research Center. He has published more than 30 papers and five books on melanin

Healthcare, Medicine,Hospitals,Hospital Management,etc

Dr. Ian Martins has been invited to join the Editors of various international journals and has been a reviewer for various journals (approx. 40). He was appointed as the Chief Editor for International Journal of Diabetes Research (2014-2017). He is a BIT Member (BIT Congress. Inc) with an H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). The total citations over the past 27 years of scientific research has accumulated to 2900. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name places Dr Martins’ publication stats RG score higher than 96% of the international researchers and is now a SCIENTIST (ResearchGate). He is now a Scientist for The Science Advisory Board (USA). He has reached the top 3% of Academia.edu. researchers and is a connecting researcher with ORCID. Prevention of over eating by food restriction improves liver lipid metabolism and nature of fat consumed is important to improving health. Contribution to biology is the peripheral sink abeta hypothesis and its relevance to organ suicide, diabetes and Alzheimer’s disease.

Global diabetes, Nutritional therap, Anti-aging therapies, stress, anxiety and depressio, Molecular neuroendocrine, low palmitic acid.

The Kolonin Laboratory is investigating the mechanisms linking aging, metabolic diseases such as type-2 diabetes, and cancer. Specifically, we have focused on the role of white and brown fat tissue dysfunction in obesity. In clinical studies and in animal models, we have shown that mesenchymal stromal cells from adipose tissue are mobilized to promote fibrosis and cancer progression. Studies elucidating the molecular mechanisms of intercellular interactions between adipose and other tissues are underway. Our group has also taken the lead in developing approaches to intervene the pathogenic functions of adipose cells. Based on the expertise in cell population separation and high throughput combinatorial peptide library screening methods, we have identified tissue-specific cell surface receptors and peptide probes. Using peptide-derived experimental drugs, we have developing a strategy to target specific cell populations in order to suppress the progression various diseases.

Cell metabolism in obesity and cancer

Dr. Carani B Sanjeevi is a Professor at the Karolinska Institute (KI) in the Department of Medicine. Dr. Sanjeevi heads a research group “Diabetes Immunology” at the Center for Molecular Medicine in Karolinska University Hospital, Solna campus in Stockholm. Dr. Sanjeevi is also Senior Advisor to the Innovation office of Karolinska Institute. Dr. Sanjeevi is the Vice-Chancellor of Sri Sathya Sai Institute of Higher Learning, India. Dr. Sanjeevi is considered to be a global authority in diabetes, particularly autoimmune diabetes.

Diabetes, Diabetic Immunology